PMC:7195088 / 8864-9886
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
164 | 163-171 | Species | denotes | patients | Tax:9606 |
165 | 317-325 | Species | denotes | patients | Tax:9606 |
166 | 331-341 | Species | denotes | SARS-Cov-2 | Tax:2697049 |
167 | 522-530 | Species | denotes | patients | Tax:9606 |
168 | 638-646 | Species | denotes | patients | Tax:9606 |
169 | 1013-1021 | Species | denotes | patients | Tax:9606 |
201 | 19-27 | Chemical | denotes | steroids | MESH:D013256 |
202 | 882-889 | Chemical | denotes | steroid | MESH:D013256 |
203 | 959-966 | Chemical | denotes | steroid | MESH:D013256 |
231 | 177-197 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
232 | 382-394 | Disease | denotes | inflammation | MESH:D007249 |
233 | 416-427 | Disease | denotes | lung injury | MESH:D055370 |
234 | 473-482 | Disease | denotes | pneumonia | MESH:D011014 |
235 | 513-521 | Disease | denotes | COVID-19 | MESH:C000657245 |
236 | 614-628 | Disease | denotes | critically ill | MESH:D016638 |
237 | 629-637 | Disease | denotes | COVID-19 | MESH:C000657245 |
238 | 652-656 | Disease | denotes | ARDS | MESH:D012128 |
239 | 682-706 | Disease | denotes | ARDS respiratory failure | MESH:D012131 |
240 | 985-1003 | Disease | denotes | non–critically ill | MESH:D016638 |
241 | 1004-1012 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 399-407 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T2 | 416-420 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 416-420 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T8 | 473-482 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T9 | 687-706 | Phenotype | denotes | respiratory failure | http://purl.obolibrary.org/obo/HP_0002878 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T39 | 177-185 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T40 | 188-197 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T41 | 331-335 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T42 | 382-394 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T43 | 421-427 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T44 | 473-482 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T45 | 513-521 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T46 | 629-637 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T47 | 652-656 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T48 | 682-686 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
T49 | 687-706 | Disease | denotes | respiratory failure | http://purl.obolibrary.org/obo/MONDO_0021113 |
T50 | 1004-1012 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T29 | 416-420 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T30 | 416-420 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T31 | 956-957 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T38 | 19-27 | Chemical | denotes | steroids | http://purl.obolibrary.org/obo/CHEBI_35341 |
T39 | 130-144 | Chemical | denotes | corticosteroid | http://purl.obolibrary.org/obo/CHEBI_50858 |
T40 | 291-305 | Chemical | denotes | corticosteroid | http://purl.obolibrary.org/obo/CHEBI_50858 |
T41 | 595-610 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T42 | 882-889 | Chemical | denotes | steroid | http://purl.obolibrary.org/obo/CHEBI_35341 |
T43 | 959-966 | Chemical | denotes | steroid | http://purl.obolibrary.org/obo/CHEBI_35341 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 382-394 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T61 | 0-11 | Sentence | denotes | Question 5. |
T62 | 12-44 | Sentence | denotes | Should steroids be administered? |
T63 | 45-198 | Sentence | denotes | So far, no definitive efficacy or effectiveness data are available on the benefit of corticosteroid administration in patients with SARS-CoV-2 infection. |
T64 | 199-342 | Sentence | denotes | As the WHO underlines, there is an important need for efficacy data from RCT for supporting corticosteroid therapy in patients with SARS-Cov-2. |
T65 | 343-789 | Sentence | denotes | However, considering that overwhelming inflammation and cytokine-related lung injury might be responsible for rapidly progressive pneumonia and clinical deterioration in COVID-19 patients, we suggest (expert opinion only) to consider administration of corticosteroids in critically ill COVID-19 patients with ARDS or with worsening of non-ARDS respiratory failure in the absence of bacterial/fungal superinfections (independent of ICU admission). |
T66 | 790-1022 | Sentence | denotes | Yet in the absence of convincing evidence, the following cannot currently be supported: (1) steroid administration stratified according to inflammatory markers; and (b) steroid administration in non–critically ill COVID-19 patients. |